Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer

Breast Cancer Research and Treatment

Volumn 118, Issue 3, 2009, Pages 651-653

  Ameziane, Najim ^a   Van Den Ouweland, Ans M W ^b   Adank, Muriel A ^a   Vijzelaar, Raymond N C P ^c   Errami, Abdellatif ^c   Dorsman, Josephine C ^a   Joenje, Hans ^a   Meijers Heijboer, Hanne ^a   Waisfisz, Quinten ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MRC HOLLAND   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 INTERACTING PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; GENE PRODUCT; NUCLEAR PROTEIN; PARTNER AND LOCALIZER OF BRCA2; UNCLASSIFIED DRUG;

ALLELE; AUTOSOMAL INHERITANCE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOMAL INSTABILITY; EXON; FAMILIAL CANCER; GENE DELETION; GENETIC SUSCEPTIBILITY; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSEUDOGENE;

BREAST NEOPLASMS; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FEMALE; GENE DELETION; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NETHERLANDS; NUCLEAR PROTEINS; RNA HELICASES; TUMOR SUPPRESSOR PROTEINS;

EID: 70449587642     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0428-8     Document Type: Letter

References (32)

1. BP Alter 2003 Cancer in Fanconi anemia, 1927-2001 Cancer 97 425 440 10.1002/cncr.11046 10.1002/cncr.11046 12518367 (Pubitemid 36133810)
2. Anglian Breast Cancer Study Group 2000 Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group Br J Cancer 83 1301 1308 10.1054/bjoc.2000. 1407 10.1054/bjoc.2000.1407
3. WL Bridge CJ Vandenberg RJ Franklin, et al. 2005 The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair Nat Genet 37 953 957 10.1038/ng1627 10.1038/ng1627 1:CAS:528: DC%2BD2MXpsFWisbs%3D 16116421 (Pubitemid 43086151)
4. AY Cao J Huang Z Hu, et al. 2009 The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives Breast Cancer Res Treat 114 457 462 10.1007/s10549-008- 0036-z 10.1007/s10549-008-0036-z 1:CAS:528:DC%2BD1MXisFSqt7o%3D 18446436
5. H Erkko B Xia J Nikkila, et al. 2007 A recurrent mutation in PALB2 in Finnish cancer families Nature 446 316 319 10.1038/nature05609 10.1038/nature05609 1:CAS:528:DC%2BD2sXivVSns78%3D 17287723 (Pubitemid 46426155)
6. WD Foulkes P Ghadirian MR Akbari, et al. 2007 Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women Breast Cancer Res 9 R83 10.1186/bcr1828 10.1186/bcr1828 18053174
7. MJ Garcia V Fernandez A Osorio, et al. 2008 Analysis of FANCB and FANCN/PALB2 Fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families Breast Cancer Res Treat 113 545 551 10.1007/s10549-008-9945-0 10.1007/s10549-008-9945-0 18302019
8. FM Giardiello JD Brensinger AC Tersmette, et al. 2000 Very high risk of cancer in familial Peutz-Jeghers syndrome Gastroenterology 119 1447 1453 10.1053/gast.2000.20228 10.1053/gast.2000.20228 1:STN:280: DC%2BD3M%2Fnt1ersw%3D%3D 11113065
9. H Gunnarsson A Arason EM Gillanders, et al. 2008 Evidence against PALB2 involvement in Icelandic breast cancer susceptibility J Negat Results Biomed 7 5 10.1186/1477-5751-7-5 10.1186/1477-5751-7-5 18637200
10. S Houghtaling C Timmers M Noll, et al. 2003 Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice Genes Dev 17 2021 2035 10.1101/gad.1103403 10.1101/gad.1103403 1:CAS:528:DC%2BD3sXms1Kntr0%3D 12893777 (Pubitemid 36999328)
11. NG Howlett T Taniguchi S Olson, et al. 2002 Biallelic inactivation of BRCA2 in Fanconi anemia Science 297 606 609 10.1126/science.1073834 10.1126/science.1073834 1:CAS:528:DC%2BD38XlslWrs7k%3D 12065746 (Pubitemid 34815345)
12. M Levitus Q Waisfisz BC Godthelp, et al. 2005 The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J Nat Genet 37 934 935 10.1038/ng1625 10.1038/ng1625 1:CAS:528:DC%2BD2MXpsFWisb0%3D 16116423 (Pubitemid 43086148)
13. O Levran C Attwooll RT Henry, et al. 2005 The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia Nat Genet 37 931 933 10.1038/ng1624 10.1038/ng1624 1:CAS:528:DC%2BD2MXpsFWisbw%3D 16116424 (Pubitemid 43086147)
14. AG Lewis J Flanagan A Marsh, et al. 2005 Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer Breast Cancer Res 7 R1005 R1016 10.1186/bcr1336 10.1186/bcr1336 1:CAS:528:DC%2BD2MXht1WmsrjL 16280053
15. ED Lynch EA Ostermeyer MK Lee, et al. 1997 Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis Am J Hum Genet 61 1254 1260 10.1086/301639 10.1086/301639 1:CAS:528: DyaK1cXntVKltQ%3D%3D 9399897 (Pubitemid 28046900)
16. D Malkin FP Li LC Strong, et al. 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1233 1238 10.1126/science.1978757 10.1126/science.1978757 1:CAS:528: DyaK3MXjslSisw%3D%3D 1978757
17. CG Mathew 2006 Fanconi anaemia genes and susceptibility to cancer Oncogene 25 5875 5884 10.1038/sj.onc.1209878 10.1038/sj.onc.1209878 1:CAS:528:DC%2BD28XhtVSgurjI 16998502 (Pubitemid 44453443)
18. GA Meijer 2007 The 13th Fanconi anemia gene identified: FANCI-importance of the 'Fanconi anemia pathway' for cellular oncology Cell Oncol 29 181 182 1:CAS:528:DC%2BD2sXksVCjtrg%3D 17452769
19. RA Oldenburg H Meijers-Heijboer CJ Cornelisse, et al. 2007 Genetic susceptibility for breast cancer: how many more genes to be found? Crit Rev Oncol Hematol 63 125 149 10.1016/j.critrevonc.2006.12.004 10.1016/j.critrevonc. 2006.12.004 1:STN:280:DC%2BD2szoslKhtg%3D%3D 17498966 (Pubitemid 46990913)
20. K Pylkas H Erkko J Nikkila, et al. 2008 Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families BMC Cancer 8 146 10.1186/1471-2407-8-146 10.1186/1471-2407-8-146 18501021 (Pubitemid 351803800)
21. N Rahman RH Scott 2007 Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players Hum Mol Genet 16 60 66 10.1093/hmg/ddm026 Spec No 1: (Pubitemid 47241843)
22. N Rahman S Seal D Thompson, et al. 2007 PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 39 165 167 10.1038/ng1959 10.1038/ng1959 1:CAS:528:DC%2BD2sXpvFeqsw%3D%3D 17200668 (Pubitemid 46184346)
23. S Reid D Schindler H Hanenberg, et al. 2007 Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer Nat Genet 39 162 164 10.1038/ng1947 10.1038/ng1947 1:CAS:528:DC%2BD2sXpvFersA%3D%3D 17200671 (Pubitemid 46184345)
24. AD Renwick S Thompson P Seal, et al. 2006 ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nat Genet 38 873 875 10.1038/ng1837 10.1038/ng1837 1:CAS:528:DC%2BD28XnsVChu7Y%3D 16832357 (Pubitemid 44141653)
25. JP Schouten CJ McElgunn R Waaijer, et al. 2002 Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res 30 e57 10.1093/nar/gnf056 10.1093/nar/gnf056 12060695
26. S Seal R Barfoot H Jayatilake, et al. 2003 Evaluation of Fanconi anemia genes in familial breast cancer predisposition Cancer Res 63 8596 8599 1:CAS:528:DC%2BD3sXhtVSqtLjM 14695169
27. S Seal D Thompson A Renwick, et al. 2006 Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat Genet 38 1239 1241 10.1038/ng1902 10.1038/ng1902 1:CAS:528:DC%2BD28XhtFeisbjJ 17033622 (Pubitemid 44646283)
28. The CHEK2 Breast Cancer Case-Control Consortium 2004 CHEK2 1100delC and susceptibility to breast cancer: a collaborative analysis involving 10, 860 breast cancer cases and 9, 065 controls from 10 studies Am J Hum Genet 74 1175 1182 10.1086/421251 10.1086/421251 (Pubitemid 38669316)
29. M Tischkowitz N Sabbaghian AM Ray, et al. 2008 Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer Prostate 68 675 678 10.1002/pros.20729 10.1002/pros.20729 18288683 (Pubitemid 351614645)
30. AH Van der Hout AM van den Ouweland RB van der Luijt, et al. 2006 A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting Hum Mutat 27 654 666 10.1002/humu.20340 10.1002/humu.20340 16683254
31. W Wang 2007 Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins Nat Rev Genet 8 735 748 10.1038/nrg2159 10.1038/nrg2159 1:CAS:528:DC%2BD2sXhtVCrsb3J 17768402 (Pubitemid 47429206)
32. B Xia JC Dorsman N Ameziane, et al. 2007 Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 Nat Genet 39 159 161 10.1038/ng1942 10.1038/ng1942 1:CAS:528:DC%2BD2sXpvFekug%3D%3D 17200672 (Pubitemid 46184344)